TY - JOUR
T1 - A third polypeptide associated with heavy and light chain subunits of class I HLA antigens in immune interferon-treated human melanoma cells
AU - Giacomini, P.
AU - Aguzzi, A.
AU - Tecce, R.
AU - Fisher, P. B.
AU - Ferrone, S.
PY - 1985
Y1 - 1985
N2 - Recombinant immune interferon (IFN-γ) increases the synthesis, expression and shedding of class I HLA antigens by the cultured human melanoma cell line Colo 38. The magnitude of the IFN-γ-induced changes in class I HLA antigens is dependent on both the dose and the time of exposure to IFN-γ and is more pronounced on the heavy chain subunit than on β2-microglobulin (β2m). In addition, a third, distinct polypeptide with a molecular mass of 14 kDa is present as a major component of the class I HLA molecular pool in IFN-γ-treated melanoma cells. As IFN-γ preferentially increases the synthesis of the heavy chain over that of β2m, the newly induced 14-kDa component appears to quantitatively replace β2m. The stoichiometric relationship between the three molecules suggests that the IFN-γ-induced 14-kDa component may be involved in the insertion of the heavy chain subunit into the plasma membrane.
AB - Recombinant immune interferon (IFN-γ) increases the synthesis, expression and shedding of class I HLA antigens by the cultured human melanoma cell line Colo 38. The magnitude of the IFN-γ-induced changes in class I HLA antigens is dependent on both the dose and the time of exposure to IFN-γ and is more pronounced on the heavy chain subunit than on β2-microglobulin (β2m). In addition, a third, distinct polypeptide with a molecular mass of 14 kDa is present as a major component of the class I HLA molecular pool in IFN-γ-treated melanoma cells. As IFN-γ preferentially increases the synthesis of the heavy chain over that of β2m, the newly induced 14-kDa component appears to quantitatively replace β2m. The stoichiometric relationship between the three molecules suggests that the IFN-γ-induced 14-kDa component may be involved in the insertion of the heavy chain subunit into the plasma membrane.
UR - http://www.scopus.com/inward/record.url?scp=0022005629&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0022005629&partnerID=8YFLogxK
U2 - 10.1002/eji.1830150915
DO - 10.1002/eji.1830150915
M3 - Article
C2 - 3930263
AN - SCOPUS:0022005629
SN - 0014-2980
VL - 15
SP - 946
EP - 951
JO - European Journal of Immunology
JF - European Journal of Immunology
IS - 9
ER -